Close

Wells Fargo Upgrades St. Jude Medical (STJ) to Outperform on Potential CardioMEMS Approval

August 9, 2013 7:41 AM EDT Send to a Friend
Wells Fargo upgraded St. Jude Medical (NYSE: STJ) from Market Perform to Outperform and raised its valuation range form $52-$53 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login